A detailed history of Cwm, LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Cwm, LLC holds 212 shares of TSVT stock, worth $633. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 76 178.95%
Holding current value
$633
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$3.85 - $5.05 $523 - $686
136 Added 178.95%
212 $1,000
Q2 2024

Jul 09, 2024

BUY
$3.6 - $5.79 $154 - $248
43 Added 130.3%
76 $0
Q1 2024

Apr 05, 2024

SELL
$3.09 - $6.0 $234 - $456
-76 Reduced 69.72%
33 $0
Q4 2023

Feb 01, 2024

SELL
$1.57 - $4.58 $56 - $164
-36 Reduced 24.83%
109 $0
Q3 2023

Oct 11, 2023

BUY
$3.14 - $11.2 $455 - $1,624
145 New
145 $1,000
Q3 2022

Oct 27, 2022

SELL
$12.56 - $17.54 $75 - $105
-6 Reduced 75.0%
2 $0
Q2 2022

Jul 28, 2022

BUY
$10.55 - $18.81 $84 - $150
8 New
8 $0
Q1 2022

Apr 21, 2022

SELL
$11.67 - $26.72 $116 - $267
-10 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$13.77 - $42.56 $137 - $425
10 New
10 $0

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.